Organon's Implanon Contraceptive Gets Second "Approvable" Letter

FDA requests more information from Organon on its implantable contraceptive Implanon following receipt of a second "approvable" letter. The company also awaits FTC clearance of a marketing and distribution agreement with Merck KGaA subsidiary Laboratoire Théramex for an oral contraceptive.